Here are five points:
1. AxioMed may now market and sell its cervical and lumbar viscoelastic total disc replacement technology in Australia.
2. The approval takes effect, immediately.
3. The technology is a next-generation disc replacement system, restoring natural disc height, stability and motion of the spine.
4. AxioMed President Jake Lubinski is meeting with surgeons in Brisbane, Sydney and Melbourne to discuss the Freedom Disc’s benefits in October.
5. The company possesses an exclusive viscoelastic material license on its proprietary Freedom Disc technology.
More articles on devices:
Global market for cervical total disc replacement devices to reach $1.75B by 2021: 5 notes
Cerapedics completes $11M in Series D Financing — 4 notes
Jensen Investment Management cuts holdings in Stryker: 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
